RSS   Newsletter   Contact   Advertise with us

AstraZeneca's trial illnesses may not be due to coronavirus shot says Oxford University

Christian Fernsby ▼ | September 17, 2020
The adverse events that led to a pause in trials evaluating AstraZeneca's coronavirus vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Trial illnesses   AstraZeneca
Safety reviews were conducted when volunteers in the trials for testing the vaccine candidate, called AZD1222 or ChAdOx1 nCoV-19, developed unexplained neurological symptoms including changed sensation or limb weakness, and the study was paused while a safety review took place, according to the document.

Topics: AstraZeneca Oxford University

“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine,” the document said.